More on RDHL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.79 |
|
|||
| Open | $0.79 | ||||
| 52 Wk High | $16.54 | ||||
| 52 Wk Low | $8.10 | ||||
| Day High | $0.87 | ||||
| Day Low | $0.78 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 677,966 | ||||
- RedHill Biopharma sets $6M private placement with warrant upside
- RedHill Biopharma Announces Up To $19.4 Million Private Placement
- RedHill initiates enforcement of $10.9 million judgment in Korea
- RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
- RedHill explores opaganib for ebola outbreak response
- RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
- RedHill's RHB-204 shows comparable efficacy to RHB-104 in lab tests
- RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
- RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
- RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
Entities mentioned with rdhl
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Rosenblatt | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Show More...
